UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Meditoxin’s future uncertain, even as final verdict nears
by Jeong Sae-im
2020-05-25 14:38
Fall in new Covid-19 cases hampers developing treatment
by Jeong Sae-im
2020-05-22 17:31
[Exclusive] Thailand recalls Medytox’s botulinum toxin
by Jeong Sae-im
2020-05-21 12:33
Plastic surgeons plead for mercy in nixing Meditoxin's license
by Jeong Sae-im
2020-05-20 15:40
‘Speed of Covid-19 vaccine development unprecedentedly fast’
by Jeong Sae-im
2020-05-18 17:04
라인
Medytox’s earnings plummet amid lawsuit against Daewoong
by Jeong Sae-im
2020-05-18 11:33
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug?
by Jeong Sae-im
2020-05-15 13:14
Why did Kolon change Invossa contract manufacturer to Lonza?
by Jeong Sae-im
2020-05-14 12:03
‘Sarpogrelate beneficial for elderly diabetic patients using antiplatelet agent’
by Jeong Sae-im
2020-05-12 17:32
Shinpoong, Bukwang stocks jump on Covid-19 drug candidates
by Jeong Sae-im
2020-05-11 12:03
라인
Daewoong’s BTX sales growth offset by lawsuit expenses
by Jeong Sae-im
2020-05-08 12:01
Cellivery sure to win licensing deal with top pharma company
by Jeong Sae-im
2020-05-07 11:27
Anticipation for Korean BTX approval in China grows strong
by Jeong Sae-im
2020-05-06 11:53
Korean drugmakers’ Q1 earnings rose despite Covid-19
by Jeong Sae-im
2020-05-01 14:45
Kolon to return $12.3 million upfront payment to Mundipharma
by Jeong Sae-im
2020-05-01 11:23
라인
Court rejects Medytox’ request to stop administrative order on BTX suspension
by Jeong Sae-im
2020-04-29 17:11
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’
by Jeong Sae-im
2020-04-28 17:35
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate
by Jeong Sae-im
2020-04-28 14:48
Kolon begins testing gene therapy for neuropathic pain in US
by Jeong Sae-im
2020-04-27 16:18
Reform panel tells regulator to retain consigned bioequivalence tests
by Jeong Sae-im
2020-04-27 13:38
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top